Follow
Laura Riccardi
Laura Riccardi
Dirigente medico di I livello, UOC Medicina Interna e Gastroenterologia, IRCCS Fondazione Policlinico Gemelli, Roma
Verified email at policlinicogemelli.it
Title
Cited by
Cited by
Year
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development
MA Zocco, E Di Stasio, R De Cristofaro, M Novi, ME Ainora, F Ponziani, ...
Journal of hepatology 51 (4), 682-689, 2009
5772009
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules
E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ...
Journal of hepatology 68 (3), 485-492, 2018
2132018
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound
MA Zocco, M Garcovich, A Lupascu, E Di Stasio, D Roccarina, ...
Journal of hepatology 59 (5), 1014-1021, 2013
892013
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
M Faccia, ME Ainora, FR Ponziani, L Riccardi, M Garcovich, A Gasbarrini, ...
World Journal of Gastroenterology 25 (31), 4437, 2019
832019
Contrast‐enhanced power Doppler of the intestinal wall in the evaluation of patients with Crohn disease
GL Rapaccini, M Pompili, R Orefice, M Covino, L Riccardi, A Cedrone, ...
Scandinavian journal of gastroenterology 39 (2), 188-194, 2004
772004
Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial
O Verrastro, S Panunzi, L Castagneto-Gissey, A De Gaetano, E Lembo, ...
The Lancet 401 (10390), 1786-1797, 2023
722023
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF‐I levels
A Fusco, L Miele, A D’Uonnolo, A Forgione, L Riccardi, C Cefalo, A Barini, ...
Clinical endocrinology 77 (4), 531-536, 2012
692012
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study
S Lancellotti, M Basso, V Veca, M Sacco, L Riccardi, M Pompili, ...
Internal and emergency medicine 11, 959-967, 2016
532016
Contrast‐enhanced gray‐scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma
M Pompili, L Riccardi, M Covino, B Barbaro, C Di Stasi, R Orefice, ...
Liver international 25 (5), 954-961, 2005
492005
Hepatocellular carcinomas< 2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients
GL Rapaccini, M Pompili, E Caturelli, M Covino, ME Lippi, S Beccaria, ...
Liver international 24 (2), 124-130, 2004
492004
Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study
G Francica, MF Meloni, L Riccardi, I de Sio, F Terracciano, E Caturelli, ...
European Journal of Radiology 105, 96-101, 2018
482018
Biopsy of liver target lesions under contrast-enhanced ultrasound guidance–a multi-center study
G Francica, MF Meloni, I de Sio, F Terracciano, E Caturelli, L Riccardi, ...
Ultraschall in der Medizin-European Journal of Ultrasound 39 (04), 448-453, 2018
402018
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver
M Pompili, L Riccardi, S Semeraro, R Orefice, F Elia, B Barbaro, M Covino, ...
Digestive and Liver Disease 40 (3), 206-215, 2008
382008
A phase II study of sunitinib in advanced hepatocellular carcinoma
C Barone, M Basso, M Biolato, M Pompili, V Rufini, L Miele, M Basso, ...
Digestive and liver disease 45 (8), 692-698, 2013
362013
Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective?
M Pompili, N De Matthaeis, A Saviano, I De Sio, G Francica, F Brunello, ...
Anticancer Research 35 (1), 325-332, 2015
342015
HepPar1-positive circulating microparticles are increased in subjects with hepatocellular carcinoma and predict early recurrence after liver resection
V Abbate, M Marcantoni, F Giuliante, FM Vecchio, I Gatto, C Mele, ...
International Journal of Molecular Sciences 18 (5), 1043, 2017
322017
Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular carcinoma
A Saviano, R Iezzi, F Giuliante, L Salvatore, C Mele, A Posa, F Ardito, ...
Journal of Vascular and Interventional Radiology 28 (11), 1512-1519, 2017
312017
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging
A Gatto, AM De Gaetano, M Giuga, M Ciresa, L Siciliani, L Miele, ...
Abdominal imaging 38, 736-744, 2013
302013
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment
D Roccarina, M Garcovich, ME Ainora, L Riccardi, M Pompili, A Gasbarrini, ...
World Journal of Hepatology 7 (14), 1866, 2015
272015
Congenital extrahepatic portosystemic shunt: description of four cases and review of the literature
FR Ponziani, M Faccia, MA Zocco, V Giannelli, A Pellicelli, GM Ettorre, ...
Journal of ultrasound 22, 349-358, 2019
252019
The system can't perform the operation now. Try again later.
Articles 1–20